Dantrolene - NDC Database
0115-4411 Mar 01, 2005
Dantrolene Sodium 25 mg Oral Capsule by Global Pharmaceuticals, Division of Impax Laboratories Inc.
Dantrolene Sodium 25 mg Oral Capsule by Global Pharmaceuticals, Division of Impax Laboratories Inc.
0115-4422 Mar 01, 2005
Dantrolene Sodium 50 mg Oral Capsule by Global Pharmaceuticals, Division of Impax Laboratories Inc.
Dantrolene Sodium 50 mg Oral Capsule by Global Pharmaceuticals, Division of Impax Laboratories Inc.
0115-4433 Mar 01, 2005
Dantrolene Sodium 100 mg Oral Capsule by Global Pharmaceuticals, Division of Impax Laboratories Inc.
Dantrolene Sodium 100 mg Oral Capsule by Global Pharmaceuticals, Division of Impax Laboratories Inc.
0143-9297 Jun 19, 2017
Dantrolene 20 mg Intravenous Injection, Powder, for Solution by West-ward Pharmaceuticals Corp
Dantrolene 20 mg Intravenous Injection, Powder, for Solution by West-ward Pharmaceuticals Corp
27505-003 Jun 04, 2012
Revonto 20 mg/60ml Intravenous Injection, Powder, Lyophilized, for Solution by Us Worldmeds, LLC
Revonto 20 mg/60ml Intravenous Injection, Powder, Lyophilized, for Solution by Us Worldmeds, LLC
42367-540 Jul 23, 2014
Ryanodex 250 mg/5ml Intravenous Injection, Suspension by Eagle Pharmaceuticals, Inc.
Ryanodex 250 mg/5ml Intravenous Injection, Suspension by Eagle Pharmaceuticals, Inc.
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.